Compare · ALGN vs ENOV
ALGN vs ENOV
Side-by-side comparison of Align Technology Inc. (ALGN) and Enovis Corporation (ENOV): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ALGN and ENOV operate in Industrial Specialties (Health Care), so they compete in similar markets.
- ALGN is the larger of the two at $12.11B, about 8.0x ENOV ($1.51B).
- Over the past year, ALGN is up 21.8% and ENOV is down 7.6% - ALGN leads by 29.5 points.
- ALGN has been more active in the news (9 items in the past 4 weeks vs 5 for ENOV).
- ALGN has more recent analyst coverage (25 ratings vs 20 for ENOV).
- Company
- Align Technology Inc.
- Enovis Corporation
- Price
- $169.11-3.25%
- $26.34-12.67%
- Market cap
- $12.11B
- $1.51B
- 1M return
- -3.16%
- +11.54%
- 1Y return
- +21.84%
- -7.63%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NYSE
- IPO
- 2001
- News (4w)
- 9
- 5
- Recent ratings
- 25
- 20
Align Technology Inc.
Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.
Enovis Corporation
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.
Latest ALGN
- SEC Form SCHEDULE 13G filed by Align Technology Inc.
- SEC Form 10-Q filed by Align Technology Inc.
- Align Technology Hosts 2026 Invisalign® Ortho Summit, Showcasing a “Beyond Possible” Vision for Connected Digital Orthodontics
- Align Technology Announces Strategic Initiatives Consistent with Long-term Growth and Shareholder Value Creation Objectives
- Align Technology Announces Second Quarter 2026 Financial Results
- Align Technology Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Align Technology Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Align Technology Announces New Innovations to Advance Invisalign® Treatment Planning and Enhance Patient Engagement Through Its Integrated Align™ Digital Platform
- Operation Smile Announces Align Technology as Title Sponsor of 34th International Student Leadership Conference for Sixth Year
- BMO Capital Markets initiated coverage on Align Tech with a new price target
Latest ENOV
- SEC Form 10-Q filed by Enovis Corporation
- Enovis Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Enovis Announces Second Quarter 2026 Results
- Enovis to Host Second Quarter 2026 Results Conference Call on August 6th
- Enovis™ Companion Animal Health Launches CT-RevitL™, the Next-Generation Laser Therapy System for Veterinary Care
- BMO Capital Markets initiated coverage on Enovis Corporation with a new price target
- Amendment: SEC Form SCHEDULE 13G/A filed by Enovis Corporation
- Director Ortiz Christine was granted 846 shares, increasing direct ownership by 3% to 25,857 units (SEC Form 4)
- SEC Form 11-K filed by Enovis Corporation
- Chief Administrative Officer Engert Oliver bought $20,920 worth of shares (1,000 units at $20.92), increasing direct ownership by 2% to 53,640 units (SEC Form 4)